跳至主要内容
临床试验/ISRCTN21681959
ISRCTN21681959已完成不适用

Effective treatment of adolescents with aggression problems in clinical and non-clinical settings: a multicentre randomised treatment efficacy trial

Karakter - Child and Adolescent Psychiatry (Netherlands)0 个研究点目标入组 120 人开始时间: 2010年4月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Full scale intelligence quotient (IQ) at least 80; total IQ (TIQ) less than 75, verbal IQ (VIQ) at least 80
  • 2. Minimal score on Modified Overt Aggression Scale (MOAS) of 5 on both initial screenings
  • 3. Age lies between 12 and 21 years, either sex
  • 4. (Psychiatric) medication free at beginning of the screening procedure
  • 5. Minimal motivation among participant and family
  • 6. Reading level of Avi 6 or 7

排除标准

  • 1. Previous ART or risperidone (6 months)
  • 2. Psychotic condition
  • 3. Severe depression
  • 4. Severe substance dependency
  • 5. Suicidal tendencies
  • 6. Pregnancy or lactation
  • 7. Major medical problems
  • 8. Epilepsy
  • 9. Cardiovascular diseases
  • 10. Regular medication which strongly interacts with risperidone
  • 11. Unable to sign informed consent

研究者

发起方
Karakter - Child and Adolescent Psychiatry (Netherlands)

相似试验